Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Genetic Characterization of the Hemagglutinin Genes of Wild-Type Measles Virus Circulating in China, 1993–2009

  • Songtao Xu ,

    Contributed equally to this work with: Songtao Xu, Yan Zhang

    Affiliation Regional Reference Measles Laboratory for the WHO Western Pacific Region, Key Laboratory of Medical Virology Ministry of Health, National Institute for Viral Disease Control and Prevention, China Center for Disease Control and Prevention, Beijing, China

  • Yan Zhang ,

    Contributed equally to this work with: Songtao Xu, Yan Zhang

    Affiliation Regional Reference Measles Laboratory for the WHO Western Pacific Region, Key Laboratory of Medical Virology Ministry of Health, National Institute for Viral Disease Control and Prevention, China Center for Disease Control and Prevention, Beijing, China

  • Zhen Zhu,

    Affiliation Regional Reference Measles Laboratory for the WHO Western Pacific Region, Key Laboratory of Medical Virology Ministry of Health, National Institute for Viral Disease Control and Prevention, China Center for Disease Control and Prevention, Beijing, China

  • Chunyu Liu,

    Affiliation Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  • Naiying Mao,

    Affiliation Regional Reference Measles Laboratory for the WHO Western Pacific Region, Key Laboratory of Medical Virology Ministry of Health, National Institute for Viral Disease Control and Prevention, China Center for Disease Control and Prevention, Beijing, China

  • Yixin Ji,

    Affiliation Regional Reference Measles Laboratory for the WHO Western Pacific Region, Key Laboratory of Medical Virology Ministry of Health, National Institute for Viral Disease Control and Prevention, China Center for Disease Control and Prevention, Beijing, China

  • Huiling Wang,

    Affiliation Regional Reference Measles Laboratory for the WHO Western Pacific Region, Key Laboratory of Medical Virology Ministry of Health, National Institute for Viral Disease Control and Prevention, China Center for Disease Control and Prevention, Beijing, China

  • Xiaohong Jiang,

    Affiliation Regional Reference Measles Laboratory for the WHO Western Pacific Region, Key Laboratory of Medical Virology Ministry of Health, National Institute for Viral Disease Control and Prevention, China Center for Disease Control and Prevention, Beijing, China

  • Chongshan Li,

    Affiliation Shanghai Center for Disease Control and Prevention, Shanghai City, China

  • Wei Tang,

    Affiliation Shanghai Center for Disease Control and Prevention, Shanghai City, China

  • Daxing Feng,

    Affiliation Henan Center for Disease Control and Prevention, Zhengzhou City, Henan Province, China

  • Changyin Wang,

    Affiliation Shandong Center for Disease Control and Prevention, Jinan City, Shandong Province, China

  • Lei Zheng,

    Affiliation Shanxi Center for Disease Control and Prevention, Taiyuan City, Shanxi Province, China

  • Yue Lei,

    Affiliation Tianjin Center for Disease Control and Prevention, Tianjin City, China

  • Hua Ling,

    Affiliation Chongqing Center for Disease Control and Prevention, Chongqing City, China

  • Chunfang Zhao,

    Affiliation Chongqing Center for Disease Control and Prevention, Chongqing City, China

  • Yan Ma,

    Affiliation Hainan Center for Disease Control and Prevention, Haikou City, Hainan Province, China

  • Jilan He,

    Affiliation Sichuan Center for Disease Control and Prevention, Chengdu City, Sichuan Province, China

  • Yan Wang,

    Affiliation Liaoning Center for Disease Control and Prevention, Shenyang City, Liaoning Province, China

  • Ping Li,

    Affiliation Shaanxi Center for Disease Control and Prevention, Xian City, Shannxi Province, China

  • Ronghui Guan,

    Affiliation Shaanxi Center for Disease Control and Prevention, Xian City, Shannxi Province, China

  • Shujie Zhou,

    Affiliation Anhui Center for Disease Control and Prevention, Hefei City, Anhui Province, China

  • Jianhui Zhou,

    Affiliation Jilin Center for Disease Control and Prevention, Changchun City, Jilin Province, China

  • Shuang Wang,

    Affiliation Jilin Center for Disease Control and Prevention, Changchun City, Jilin Province, China

  • Hong Zhang,

    Affiliation Hunan Center for Disease Control and Prevention, Changsha City, Hunan Province, China

  • Huanying Zheng,

    Affiliation Guangdong Center for Disease Control and Prevention, Guangzhou City, Guangzhou Province, China

  • Leng Liu,

    Affiliation Guangdong Center for Disease Control and Prevention, Guangzhou City, Guangzhou Province, China

  • Hemuti Ma,

    Affiliation Xinjiang Center for Disease Control and Prevention, Urumchi City, Xinjiang Province, China

  • Jing Guan,

    Affiliation Xinjiang Center for Disease Control and Prevention, Urumchi City, Xinjiang Province, China

  • Peishan Lu,

    Affiliation Jiangsu Center for Disease Control and Prevention, Nanjing City, Jiangsu Province, China

  • Yan Feng,

    Affiliation Zhejiang Center for Disease Control and Prevention, Hangzhou City, Zhejiang Province, China

  • Yanjun Zhang,

    Affiliation Zhejiang Center for Disease Control and Prevention, Hangzhou City, Zhejiang Province, China

  • Shunde Zhou,

    Affiliation Jiangxi Center for Disease Control and Prevention, Nanchang City, Jiangxi Province, China

  • Ying Xiong,

    Affiliation Jiangxi Center for Disease Control and Prevention, Nanchang City, Jiangxi Province, China

  • Zhuoma Ba,

    Affiliation Qinghai Center for Disease Control and Prevention, Xining City, Qinghai Province, China

  • Hui Chen,

    Affiliation Ningxia Center for Disease Control and Prevention, Yinchuan City, Ningxia Province, China

  • Xiuhui Yang,

    Affiliation Fujian Center for Disease Control and Prevention, Fuzhou City, Fujian Province, China

  • Fang Bo,

    Affiliation Heilongjiang Center for Disease Control and Prevention, Harbin City, Heilongjiang Province, China

  • Yujie Ma,

    Affiliation Heilongjiang Center for Disease Control and Prevention, Harbin City, Heilongjiang Province, China

  • Yong Liang,

    Affiliation Hebei Center for Disease Control and Prevention, Shijiazhuang City, Hebei Province, China

  • Yake Lei,

    Affiliation Hubei Center for Disease Control and Prevention, Wuhan City, Hubei Province, China

  • Suyi Gu,

    Affiliation Inner Mongolia Center for Disease Control and Prevention, Hohhot City, Inner Mongolia Province, China

  • Wei Liu,

    Affiliation Guangxi Center for Disease Control and Prevention, Nanning City, Guangxi Province, China

  • Meng Chen,

    Affiliation Beijing Center for Disease Control and Prevention, Beijing City, China

  • David Featherstone,

    Affiliation Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland

  • Youngmee Jee,

    Affiliation Expanded Programme on Immunization, Western Pacific Regional Office, World Health Organization, Manila, Philippines

  • William J. Bellini,

    Affiliation Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  • Paul A. Rota,

    Affiliation Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America

  •  [ ... ],
  • Wenbo Xu

    wenbo_xu1@yahoo.com.cn

    Affiliation Regional Reference Measles Laboratory for the WHO Western Pacific Region, Key Laboratory of Medical Virology Ministry of Health, National Institute for Viral Disease Control and Prevention, China Center for Disease Control and Prevention, Beijing, China

  • [ view all ]
  • [ view less ]

Abstract

Background

China experienced several large measles outbreaks in the past two decades, and a series of enhanced control measures were implemented to achieve the goal of measles elimination. Molecular epidemiologic surveillance of wild-type measles viruses (MeV) provides valuable information about the viral transmission patterns. Since 1993, virologic surveillnace has confirmed that a single endemic genotype H1 viruses have been predominantly circulating in China. A component of molecular surveillance is to monitor the genetic characteristics of the hemagglutinin (H) gene of MeV, the major target for virus neutralizing antibodies.

Principal Findings

Analysis of the sequences of the complete H gene from 56 representative wild-type MeV strains circulating in China during 1993–2009 showed that the H gene sequences were clustered into 2 groups, cluster 1 and cluster 2. Cluster1 strains were the most frequently detected cluster and had a widespread distribution in China after 2000. The predicted amino acid sequences of the H protein were relatively conserved at most of the functionally significant amino acid positions. However, most of the genotype H1 cluster1 viruses had an amino acid substitution (Ser240Asn), which removed a predicted N-linked glycosylation site. In addition, the substitution of Pro397Leu in the hemagglutinin noose epitope (HNE) was identified in 23 of 56 strains. The evolutionary rate of the H gene of the genotype H1 viruses was estimated to be approximately 0.76×10−3 substitutions per site per year, and the ratio of dN to dS (dN/dS) was <1 indicating the absence of selective pressure.

Conclusions

Although H genes of the genotype H1 strains were conserved and not subjected to selective pressure, several amino acid substitutions were observed in functionally important positions. Therefore the antigenic and genetic properties of H genes of wild-type MeVs should be monitored as part of routine molecular surveillance for measles in China.

Introduction

Measles virus (MeV), a member of the genus Morbillivirus of the family Paramyxoviridae, is an enveloped virus with a nonsegmented negative-sense RNA genome. Measles virus is highly contagious and causes a disease characterized by high fever, cough, coryza, conjunctivitis, and appearance of a maculopapular rash [1]. Despite the existence of an effective vaccine, many developing countries are still experiencing endemic measles. In China, measles remains a major public health concern because of frequent outbreaks although the two effective vaccines, Shanghai191 (S191) and Changchun47 (C47) have been widely used to prevent illness. In 2005, China set a goal of measles elimination by 2012, and the goverment has been making great efforts to achieve this goal including strengthening routine immunization, expanding epidemiologic and virologic surveillance, increasing vaccination of internal mobile poopulations, and initiation of large-scale supplemental immunization acitivities (SIA). For example, the SIA of September 2010 targeted 100 million children and teenagers.

MeV is a monotypic virus, but 24 genotypes (A, B1–B3, C1–C2, D1–D11, E, F, G1–G3 and H1–H2) have been described [2][4]. In China, genotyping of wild-type MeV strains circulating during 1993–1994 led to identification of a novel genotype, H1 [5]. Since then, continuous molecular surveillance revealed that genotype H1 MeVs were endemic throughout mainland China. The genotype H1 sequences could be divided into 2 clusters based on phylogenetic analysis of the 450 nucleotides coding for the carboxyl-terminus of the nucleoprotein (N) gene (N-450). Cluster1 viruses have been the most frequently detected strains since 2000 and cluster2 viruses were not detected after 2005 [6][10].

The genome of MeV contains six genes that encode the nucleoprotein (N), phosphoprotein (P), matrix (M), fusion (F), hemagglutinin (H), and polymerase (L) proteins. The H protein, an 80 kilodalton (kD) glycoprotein, is responsible for receptor-binding and is the major target for neutralizing antibodies [11]. The H protein usually contains five potential N-linked glycosylation sites which are clustered at amino acid positions 168, 187, 200, 215, 238. Some genotypes have an additional N-linked glycosylation site at position 416 [12], [13]. MeV uses up to three cellular receptors, including Signaling Lymphocyte Activation Molecule (SLAM, CD150), CD46 and nectin-4 [14], [15], [16], [17] . The H protein contains 13 cysteine residues, seven of which are located at amino acid positions 287, 300, 381, 394, 494, 579, 583. These amino acids play a critical role in maintaining the antigenic structure of the H protein [18]. A few linear neutralizing epitopes have been identified using monoclonal antibodies [19], [20].

We carried out this study to describe the genetic variability of the H genes of MeVs circulating throughout China over a 17-year period. This work provides the first detailed report of the sequences of the H genes of Chinese MeVs as well as a unique opportunity to analyze genetic changes in the H genes from a single genotype of MeV over an extended period of time.

Results

The epidemiologic profile of measles in China

The number of reported measles cases and deaths and the incidence of measles were obtained from the National Notifiable Disease Report System (NNDRS) (Figure 1). Nationwide outbreaks of measles occurred every 3–4 years because of the accumulation of susceptible children, especially in areas with lower routine immunization coverage. Viral isolates were obtained throughout the period shown in Figure 1.

thumbnail
Figure 1. Reported measles cases and incidence in China, 1991–2009.

The number above the column represents the number of representative measles strains selected for the complete H gene sequence analysis. Blue bars indicate the number of reported measles cases and yellow solid diamonds indicate the incidence (/100,000 population) of each year, the Arabic numerals above the x-axis indicates the number of deaths. X-axis denotes year, y-axis on left denotes reported number of cases and y-axis on right denotes the incidence per 100,000 population.

https://doi.org/10.1371/journal.pone.0073374.g001

Genetic characterization of the H genes of Chinese MeVs

The H glycoprotein is the major target for neutralizing antibodies directed against the virus. For this report, 46 new H gene sequences were obtained from viral isolates and compared to 10 previously published H gene sequences. Analysis of the predicted amino acid sequences of the H proteins showed that genotype H1 cluster1 isolates circulating in 2000–2009 had a conserved substitution of Ser240Asn, which removed the predicted N-linked glycosylation site at amino acid 238 (Figure 2). In addition, 23 of 56 genotype H1 strains showed an exchange of Pro397Leu, this 397 amino acid is a part of the linear hemagglutinin noose epitope (HNE) which is located at amino acids 379–410. However, all of the putative binding sites for SLAM and CD46 were conserved (Figure 2). The seven cysteine residues presumably responsible for the antigenic structure of the H molecules (amino acids 287, 300, 381, 394, 494, 579, and 583) were highly conserved [18]. The amino acids 236–250 predicting B Cell epitopes (BCE) were relatively conserved [21], excluding the previously described substitutions at amino acids 240 and 243 in the Chinese vaccine strains (Arg243, Gly243).

thumbnail
Figure 2. Alignment of the predicted amino acid sequences of the partial H gene.

The variation of amino acid Ser240Asn (highlighted in blue) leads to the absence of a glycosylation site; the exchange of Pro397Leu (highlighted in pink) that results in loss of recognition of two monoclonal antibodies directed against HNE; the amino acid residues of putative binding sites for CD46, SLAM and seven cysteine residues were highlighted in red, yellow and purple, respectively.

https://doi.org/10.1371/journal.pone.0073374.g002

The complete H gene sequences of 56 H1 MeVs, the Chinese vaccine strains, and other genotype reference strains were used for phylogenetic analysis (Figure 3). The sequences of genotype H1 isolates could be divided into at least 2 clusters without obvious chronological and geographical distributions. Fifty-one isolates belonged to cluster1 which also contained a few more diverse strains isolated in 1993–1994. Five isolates belonged to cluster2. The topology of the tree suggested that multiple chains of virus transmission were present and the sequences showed no temporal or geographic distribution (Figure 3).

thumbnail
Figure 3. Phylogenetic relationship based on the complete H gene sequences.

Neighbour-joining tree was reconstructed with full-length H gene sequences from 56 genotype H1 wild-type measles isolates from mainland China, the WHO reference strains of each genotype and Chinese vaccine strains. The sequences of the circulating strains in 1993–1994 and in 2000–2009 are indicated by symbol “▴” and “•”, respectively, each color of symbol “•” represents the annually circulating strains. The genotype H2 reference strain below cluster 2 which is also marked by a triangle was identified in 1994, China. The branches for the different lineages are marked by various colors. The WHO standard name of MeVs and GenBank accession numbers of all the sequences are available in the figure. Numbers at nodes represent the percentage of 1,000 bootstrap replicates (values <70 are not shown). Bar, 0.005 nucleotide substitutions per site.

https://doi.org/10.1371/journal.pone.0073374.g003

The evolutionary rates of the H gene for the genotype H1 and H1 cluster1 viruses were 0.76×10−3 and 0.65×10−3 substitutions per site per year, respectively. The dN and dS were calculated for selection pressure analysis, the results indicated the dN/dS ratios for the genotype H1 and H1 cluster1 were 0.21 and 0.20, respectively.

Discussion

The results of the sequence analysis reported here provide another example of the genetic stability of MeV. The H genes of 56 MeVs isolated over a 17 year time span showed remarkable conservation of functionally important amino acids. In particular, the stability of the amino acids comprising the receptor-binding sites likely contributes to the monotypic nature of MeV [22][24]. The cysteine residues responsible for the tertiary structure of the H molecule were also highly conserved [18] . The amino acid substitutions detected appeared to be the result of a gradual accumulation of genetic changes and the degree to which these amino acid mutations contribute to antigenic changes of the H protein is being investigated.

The H protein of MeV usually contains five or six potential N-linked glycosylation sites. The fifth site, located at amino acid 238, was absent in all the H1 cluster1 strains circulating in 2000–2009. Hu et al. showed that the fifth glycosylation site had minimal impacted on the processing and antigenicity of the H molecule, though the other glycosylation sites played important functional roles [25], [26]. Shi et al. demonstrated that the neutralization titers of serum samples from human vaccinees were lower against some of the wild-type viruses than against vaccines strains and antigenic differences have been detected by monoclonal antibodies directed against the H protein [27], [28]. The linear hemagglutinin noose epitope (HNE; amino acids 379–410) was highly stable in both vaccine and wild-type strains [29][31]. We found that nearly half of the genotype H1 strains showed an exchange of Pro397Leu, a mutation that results in loss of recognition of two monoclonal antibodies directed against HNE [32]. Though the H protein of a few genotype H1 MeVs would presumably not be recognized by antibodies directed against the HNE, serum from human vaccines neutralized H1 MeVs with either Pro or Leu at position 397 [36]. This conservation of neutralizing epitopes was also noted by Bouche et al.[33]. The strong conservation of the seven cysteine residues also clarified the antigenic structure and processing of the H molecules [18]. The Chinese vaccines have been very effective at dramatically reducing the incidence of measles in China. However, since amino acid substitutions were observed on the H protein between genotype H1 strains and the Chinese vaccine strains, it will be important to continually monitor the antigenicity and genetic characteristics of the H protein of circulating MeVs.

Molecular surveillance of wild-type MeVs from 1993 to 2008 based on analysis of the 450 nucleotides coding for the carboxyl-terminus of the N gene indicated that genotype H1 cluster1 viruses were continuously circulating in China [6], [9], [10]. The phylogenetic tree constructed based on the H gene sequences, confirmed the analysis based on the N-450 sequences that genotype H1 cluster1 viruses were the predominant strains in China during 1993–2009. Cluster1 was divided into 3 lineages and lineages 1 and 2 were considered to be an intermediate group that appeared to be the predominant strains in 1993–1994 and have not been found since 1995 [6][8]. Lineage 3 was further divided into lineage 3a and 3b and all of the strains isolated from 2000–2009 belonged to lineage 3b. Genotype H1 cluster2 viruses have not been detected since 2002. Although there was a temporal distribution among the MeV strains of the 3 lineages of cluster1, multiple transmission chains of were apparent in lineage 3b without an obvious temporal distribution (Figure 3). The observation that the phylogenetic analysis based on the H gene sequences gave results that were consistent with results obtained after analysis of the much larger set of N-450 sequences suggests that the H gene sequences provide a reasonable representation of MeVs circulating in China. The caveat is that virologic surveillance is incomplete and we cannot be sure that all of the lineages were represented by the H gene or N-450 data sets.

Viral RNA polymerases have high error rates due to the lack of proofreading ability, which leads to the high mutation rate of the viral genome and rapid evolutionary rates. In some cases, these mutations allow the virus to adapt to a new host or escape the host's anti-viral responses. This study estimated that the mutation rate of the predominant group (Cluster1) of genotype H1 MeVs was 0.65×10−3 substitutions per site per year based on the analysis of the complete H genes. This rate is slightly higher than the rates previously reported by Jenkins et al. (0.4×10−3) and Rima et al. (0.5×10−3), but it is low when compares with some other RNA viruses such as enterovirus 71 (3.18×10−3), human influenza A (1.8×10−3), and equivalent to the mutation rates reported for dengue virus and human rotavirus [34][36]. The dN to dS ratios for both H1 and H1 cluster1 were <1 that demonstrating that the H gene of the MeVs analyzed was not subject to antigenic selection. Rather, the data suggest that the amino acid substitutions in the H gene were the result of random genetic drift, rather than accumulated mutations.

In summary, the H gene of the MeVs endemic in China should be monitored continuously for genetic variations that could affect antigenic properties. Our group is currently using the bioinformatics methods to understand the disappearance of cluster2 and map the antigenic domains on the 3-dimentional crystal structure of the H protein. This information will be helpful to evaluate the efficiency of the current vaccines.

Materials and Methods

Epidemiologic information

As a class B reportable disease, suspected measles cases are reported to the National Notifiable Disease Reporting System (NNDRS) in China. The number of measles cases, the annual measles incidence, and measles-associated deaths were retrieved directly from NNDRS reports.

Selection and isolation of viruses

In 2001, the National Measles Laboratory Network was established to carry out measles surveillance in China. Genotyping and genetic analysis of wild-type viruses were included in the laboratory surveillance. These strains were chosen from viral strains bank of the National Measles Laboratory (NML) to achieve representative chronological and geographical distributions (covering 25 provinces). All of the selected strains were cultured and propagated in Vero/hSLAM cells, which were maintained in minimal essential medium supplemented with 2% fetal bovine serum [37]. Viruses were harvested when the classic measles CPE was maximal.

Determination of the complete H gene nucleotide sequences

Total viral RNA was extracted from the infected Vero/hSLAM cells with the QIAamp Viral RNA mini kit (Qiagen, Valencia, CA) according to the manufacturer's instruction. The entire protein-coding region of the H gene was amplified with the sequence-specific primers (Table 1) by using the SuperScript™III One-Step RT-PCR kit (Invitrogen, Carlsbad, CA). The PCR products were sequenced directly after purification (QIA gel extraction kit, Qiagen, Valencia, CA) by the dye terminator method (BigDye Terminator, version 3.1, cycle sequencing kit; Applied Biosystems) in an ABI PRISM 3100 genetic analyzer (Applied Biosystems, Hitachi, Japan). The primers used for sequencing are listed in Table 1.

thumbnail
Table 1. Primers used for amplification and sequencing of the entire H gene.

https://doi.org/10.1371/journal.pone.0073374.t001

Sequence and phylogenetic analysis

Sequence data were assembled and edited using Sequencher software version 4.0.5 (GeneCodes, Ann Arbor, MI); sequence alignments were assembled with BioEdit version 7.0 (Tom Hall, North Carolina State University, Raleigh, NC), and phylogenetic trees were constructed by the neighbor-joining method (1000 bootstraps) using MEGA version 4.0 [38], [39]. The 24 WHO reference genotype strains, 56 genotype H1 strains and two Chinese vaccine strains were used to construct the phylogenetic trees.

Estimation of evolutionary rate

Because of the lack of a true “ancestor” strain and the apparent presence of multiple lineages, to estimate the evolutionary rate of genotype H1 and genotype H1 cluster1 viruses, we used the oldest strain in each target group as a reference. The evolutionary distances were calculated by overall mean scope according to the Kimura two-parameter method of the MEGA program. The dS (synonymous substitutions per synonymous site), dN (non-synonymous substitutions per non-synonymous site), and the ratios of dS to dN values also were analyzed.

Nucleotide sequence accession numbers

Nucleotide sequences of the complete H gene (1854 nucleotides) of the 46 measles virus strains which were determined have been submitted and deposited in the GenBank database, the accession numbers are JN997482 to JN997527. Accession numbers of Chinese circulating strains in 1993–1994, all the WHO reference strains of each genotype and Chinese vaccine strains are given in Figure 3.

Acknowledgments

We thank all the provincial and prefectural measles and rubella laboratory staff and the epidemiologists in mainland China for providing clinical specimens, isolates, and epidemiologic data; we also thank WHO HQ, WPRO, and US CDC for the technical support.

Author Contributions

Conceived and designed the experiments: SX D. Featherstone Y. Jee WJB WX . Performed the experiments: SX Y. Ji HW NM XJ . Analyzed the data: SX ZZ Yan Zhang WX Y. Ji. Contributed reagents/materials/analysis tools: C. Liu WT D. Feng CW LZ Yue Lei HL CZ Yan Ma C. Li JH YW P. Li RG Shujie Zhou JZ SW HZ HYZ LL HM JG P. Lu YF Yanjun Zhang Shunde Zhou YX ZB HC XY FB Yujie Ma Y. Liang Yake Lei SG WL MC. Wrote the paper: SX ZZ PAR.

References

  1. 1. Griffin DEB, Bellini WJ (1996) Measles viruses. In: Fields,BN, Knipe, DM, Howley, PM (Eds), Fields virology, third ed Lippincott-Raven, Philadelphia, PA, pp 1267–1296.
  2. 2. Rota PA, Brown K, Mankertz A, Santibanez S, Shulga S, et al. (2011) Global distribution of measles genotypes and measles molecular epidemiology. J Infect Dis 204 (Suppl 1) S514–523.
  3. 3. Zhang Y, Ding Z, Wang H, Li L, Pang Y, et al. (2010) New measles virus genotype associated with outbreak, China. Emerg Infect Dis 16: 943–947.
  4. 4. WHO (2012) Weekly Epidemiological Record (WER) 87: 73–80.
  5. 5. Xu W, Tamin A, Rota JS, Zhang L, Bellini WJ, et al. (1998) New genetic group of measles virus isolated in the People's Republic of China. Virus Res 54: 147–156.
  6. 6. Zhang Y, Ji Y, Jiang X, Xu S, Zhu Z, et al. (2008) Genetic characterization of measles viruses in China, 2004. Virol J 5: 120.
  7. 7. Ji Y, Zhang Y, Xu S, Zhu Z, Zuo S, et al. (2009) Measles resurgence associated with continued circulation of genotype H1 viruses in China, 2005. Virol J 6: 135.
  8. 8. Ji Y, Xu S, Zhang Y, Zhu Z, Mao N, et al. (2010) Genetic characterization of wild-type measles viruses isolated in China, 2006–2007. Virol J 7: 105.
  9. 9. Zhang Y, Zhu Z, Rota PA, Jiang X, Hu J, et al. (2007) Molecular epidemiology of measles viruses in China, 1995–2003. Virol J 4: 14.
  10. 10. Zhang Y, Xu S, Wang H, Zhu Z, Ji Y, et al. (2012) Single endemic genotype of measles virus continuously circulating in China for at least 16 years. PLoS One 7: e34401.
  11. 11. Liffick SL, Thi Thoung N, Xu W, Li Y, Phoung Lien H, et al. (2001) Genetic characterization of contemporary wild-type measles viruses from Vietnam and the People's Republic of China: identification of two genotypes within clade H. Virus Res 77: 81–87.
  12. 12. Saito H, Nakagomi O, Morita M (1995) Molecular identification of two distinct hemagglutinin types of measles virus by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP). Mol Cell Probes 9: 1–8.
  13. 13. Rota JS, Hummel KB, Rota PA, Bellini WJ (1992) Genetic variability of the glycoprotein genes of current wild-type measles isolates. Virology 188: 135–142.
  14. 14. Masse N, Ainouze M, Neel B, Wild TF, Buckland R, et al. (2004) Measles virus (MV) hemagglutinin: evidence that attachment sites for MV receptors SLAM and CD46 overlap on the globular head. J Virol 78: 9051–9063.
  15. 15. Vongpunsawad S, Oezgun N, Braun W, Cattaneo R (2004) Selectively receptor-blind measles viruses: Identification of residues necessary for SLAM- or CD46-induced fusion and their localization on a new hemagglutinin structural model. J Virol 78: 302–313.
  16. 16. Muhlebach MD, Mateo M, Sinn PL, Prufer S, Uhlig KM, et al. (2011) Adherens junction protein nectin-4 is the epithelial receptor for measles virus. Nature 480: 530–533.
  17. 17. Leonard VH, Sinn PL, Hodge G, Miest T, Devaux P, et al. (2008) Measles virus blind to its epithelial cell receptor remains virulent in rhesus monkeys but cannot cross the airway epithelium and is not shed. J Clin Invest 118: 2448–2458.
  18. 18. Hu A, Norrby E (1994) Role of individual cysteine residues in the processing and antigenicity of the measles virus haemagglutinin protein. J Gen Virol 75 (Pt 9) 2173–2181.
  19. 19. Hu A, Sheshberadaran H, Norrby E, Kovamees J (1993) Molecular characterization of epitopes on the measles virus hemagglutinin protein. Virology 192: 351–354.
  20. 20. Makela MJ, Salmi AA, Norrby E, Wild TF (1989) Monoclonal antibodies against measles virus haemagglutinin react with synthetic peptides. Scand J Immunol 30: 225–231.
  21. 21. Alkhatib G, Briedis DJ (1986) The predicted primary structure of the measles virus hemagglutinin. Virology 150: 479–490.
  22. 22. Hashiguchi T, Kajikawa M, Maita N, Takeda M, Kuroki K, et al. (2007) Crystal structure of measles virus hemagglutinin provides insight into effective vaccines. Proc Natl Acad Sci U S A 104: 19535–19540.
  23. 23. Tahara M, Ohno S, Sakai K, Ito Y, Fukuhara H, et al. (2013) The receptor-binding site of the measles virus hemagglutinin protein itself constitutes a conserved neutralizing epitope. J Virol 87: 3583–3586.
  24. 24. Tahara M, Ito Y, Brindley MA, Ma X, He J, et al. (2013) Functional and structural characterization of neutralizing epitopes of measles virus hemagglutinin protein. J Virol 87: 666–675.
  25. 25. Bolt G, Pedersen IR, Blixenkrone-Moller M (1999) Processing of N-linked oligosaccharides on the measles virus glycoproteins: importance for antigenicity and for production of infectious virus particles. Virus Res 61: 43–51.
  26. 26. Hu A, Cattaneo R, Schwartz S, Norrby E (1994) Role of N-linked oligosaccharide chains in the processing and antigenicity of measles virus haemagglutinin protein. J Gen Virol 75 (Pt 5) 1043–1052.
  27. 27. Tamin A, Rota PA, Wang ZD, Heath JL, Anderson LJ, et al. (1994) Antigenic analysis of current wild type and vaccine strains of measles virus. J Infect Dis 170: 795–801.
  28. 28. Shi J, Zheng J, Huang H, Hu Y, Bian J, et al. (2011) Measles incidence rate and a phylogenetic study of contemporary genotype H1 measles strains in China: is an improved measles vaccine needed? Virus Genes 43: 319–326.
  29. 29. Ziegler D, Fournier P, Berbers GA, Steuer H, Wiesmuller KH, et al. (1996) Protection against measles virus encephalitis by monoclonal antibodies binding to a cystine loop domain of the H protein mimicked by peptides which are not recognized by maternal antibodies. J Gen Virol 77 (Pt 10) 2479–2489.
  30. 30. Ertl OT, Wenz DC, Bouche FB, Berbers GA, Muller CP (2003) Immunodominant domains of the Measles virus hemagglutinin protein eliciting a neutralizing human B cell response. Arch Virol 148: 2195–2206.
  31. 31. Santibanez S, Niewiesk S, Heider A, Schneider-Schaulies J, Berbers GA, et al. (2005) Probing neutralizing-antibody responses against emerging measles viruses (MVs): immune selection of MV by H protein-specific antibodies? J Gen Virol 86: 365–374.
  32. 32. Finsterbusch T, Wolbert A, Deitemeier I, Meyer K, Mosquera MM, et al. (2009) Measles viruses of genotype H1 evade recognition by vaccine-induced neutralizing antibodies targeting the linear haemagglutinin noose epitope. J Gen Virol 90: 2739–2745.
  33. 33. Bouche FB, Ertl OT, Muller CP (2002) Neutralizing B cell response in measles. Viral Immunol 15: 451–471.
  34. 34. Zhang Y, Wang J, Guo W, Wang H, Zhu S, et al. (2011) Emergence and transmission pathways of rapidly evolving evolutionary branch C4a strains of human enterovirus 71 in the Central Plain of China. PLoS One 6: e27895.
  35. 35. Jenkins GM, Rambaut A, Pybus OG, Holmes EC (2002) Rates of molecular evolution in RNA viruses: a quantitative phylogenetic analysis. J Mol Evol 54: 156–165.
  36. 36. Rima BK, Earle JA, Baczko K, ter Meulen V, Liebert UG, et al. (1997) Sequence divergence of measles virus haemagglutinin during natural evolution and adaptation to cell culture. J Gen Virol 78 (Pt 1) 97–106.
  37. 37. Ono N, Tatsuo H, Hidaka Y, Aoki T, Minagawa H, et al. (2001) Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor. J Virol 75: 4399–4401.
  38. 38. Tamura K, Dudley J, Nei M, Kumar S (2007) MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24: 1596–1599.
  39. 39. Kumar S, Nei M, Dudley J, Tamura K (2008) MEGA: a biologist-centric software for evolutionary analysis of DNA and protein sequences. Brief Bioinform 9: 299–306.